跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYDRASO 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LYDRASO 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LYDRASO 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Tad Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 20, 2020
Approval ID
160584f8f3d981f1
Company
Tad Pharma Gmbh
Type
Standard
Approval Details
Approval Id
160584f8f3d981f1
Drug Cima Aemps Name
LYDRASO 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85503
Holder Company Name
Tad Pharma Gmbh
Marketing Company Name
Krka Farmaceutica S.L.
Holder Company Detail Path
/organization/tad-pharma-gmbh
Authorization Date
2020-10-20
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Tad Pharma Gmbh
Company Detail Path
/organization/tad-pharma-gmbh
Company Information
Pharmaceutical Company Name
TAD Pharma GmbH
Country Name
Germany
City Name
cuxhaven,niedersachsen,country_de
Address
Heinz-Lohmann-Str. 5
Active Ingredients
LACOSAMIDA
150 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 20, 2020
Approval ID
160584f8f3d981f1
Type
Standard
Back to CIMA-AEMPS Approvals